Monsenso A/S (CPH: MONSO)
Denmark
· Delayed Price · Currency is DKK 0.336
-0.044 (-11.58%)
Dec 20, 2024, 4:13 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 22.39 million as of December 20, 2024. Its market cap has increased by 128.22% in one year.
Market Cap
22.39M
Enterprise Value
16.42M
Revenue
10.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 22.39M, a decrease of -76.89%. That is a compound annual growth rate of -27.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 22.39M | 153.49% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | 163.08M | 68.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk A/S | 2,606.81B |
| Coloplast A/S | 179.48B |
| Genmab A/S | 92.87B |
| Demant A/S | 56.34B |
| Zealand Pharma A/S | 53.44B |
| H. Lundbeck A/S | 38.79B |
| H. Lundbeck A/S | 38.52B |
| ALK-Abelló A/S | 35.68B |